Medical Design & Manufacturing East

Extensive Learning Platform for Professionals of Medical Technology. Medical Design & Manufacturing (MD&M) East is the largest MedTech event on the East Coast, connecting one with thousands of engineers and executives, as well as hundreds of leading suppliers. It boasts to provide an opportunity to get hands-on with top products and the latest technologies in medical diagnosis. Thousands gather to gain critical knowledge and a better understanding of the latest industry innovations and emerging technologies in the Business Services & medical diagnosis and research.

Spotlight


OTHER PAST CONFERENCES

AI x PHARMA x HEALTH 2024

March 27, 2024 | Finland

Welcome to learn about artificial intelligence (AI) and its transformative impact on the pharmaceutical industry and healthcare at AI x PHARMA x HEALTH 2024!

Pharma Contract Manufacturing Conference Europe

April 9-11, 2024 | Germany

Welcome To The Industry’s Leading Pharma Contract Manufacturing Event. Pharma Contract Manufacturing is the only event to focus specifically on how to improve CMO selection and partnering. We appreciate the critical role these play in delivering success for both patients and the organisation-at-large. We also appreciate that the bedrock of these relationships is collaboration from both sides, which is why we bring together leading pharmaceutical companies and CMOs to benchmark best practice in this area. Selecting the right CMO partner is the critical decision in getting high-quality products to patients. If this relationship fails, we fail. Our companies and patients can’t afford for us to get this decision wrong. That’s why Pharma IQ is bringing together partners from across the industry to collaborate on how we make these relationships work both now and in the future. Because for the patient to succeed, we need to succeed.

National Medtech & Biotech Summit 2024

May 28-29, 2024 | Ireland

Ireland is now a well-established global leader in MedTech and Biotechnology. Nine of the world’s top ten MedTech companies have a base in Ireland. Indeed, Ireland is one of the top seven employers of MedTech professionals in Europe, with more than 40,000 people currently working in the sector. Furthermore, there are now more than 450 MedTech companies operating in Ireland with over 60% having been developed locally. In the Biotechnology sector, there are well over 300 companies operating in Ireland. Indeed, all but one of the world’s 25 largest Biotech and Pharma companies have a presence in Ireland. In recent years, capital investment of about $10 billion has been made in new facilities by the BioPharma industry in Ireland. This is believed to represent close to the biggest wave of investment in new BioTech facilities anywhere in the world, according to the IDA Ireland (Ireland’s inward investment promotion agency). The Biotechnology Innovation Organisation defines Biotechnology at its simplest as technology based on biology – Biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. Medical Technologies relate to prevention, diagnosis, monitoring, treatment, and care, and often utilise new technologies such as artificial intelligence or machine learning, according to MedTech Europe. The National MedTech & Biotech Summit, which is being held on 28th - 29th May 2024 at the RDS Simmonscourt, in Dublin, will highlight the key trends and challenges facing the sector, while also showcasing the latest innovations and developments in best practice, and the technological solutions available. The event will focus on the global growth opportunities, as well as major trends such as digital health and the shift to value-based healthcare and the long-term implications for manufacturers and business models.

Pharma 2024

April 16-18, 2024 | Spain

The world’s leading cross-functional event for pharma changemakers Pharma’s role within the healthcare system is weakening. Increased demand, economic strains, suffocating regulatory change and a widening access gap is impacting future pipelines and commercial innovations reaching patients. Siloed functions too often compete with each other instead of complement each other, failing to rally behind a common purpose. Internal forces need to come together to secure a future where better medicines support a value proposition that resonates with our patients, payers, policy makers, HTAs and customers. No one function can do this alone, we must act as one. That’s why over 1,200 of the world's leading pharma changemakers from commercial, marketing, medical affairs, patient engagement, market access, RWE, and digital health are gathering under one roof in Barcelona at Reuters Events: Pharma 2024. We will draw up a new blueprint to bridge and align internal workforces while rewriting pharma’s value proposition, cementing its role as an integral pillar of the healthcare system. At this event, together, we will become the trusted source for scientific information, transform digital potential into meaningful patient outcomes, adapt to the incoming JCA legislation and harness growing data sources that will deliver value to customers and growing patient population needs.